Actinogen Medical Statistics
Total Valuation
Actinogen Medical has a market cap or net worth of 45.95 million. The enterprise value is 40.26 million.
| Market Cap | 45.95M |
| Enterprise Value | 40.26M |
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +20.69% |
| Shares Change (QoQ) | +10.72% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.31B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.63 |
| EV / Sales | 6.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.56 |
Financial Position
The company has a current ratio of 13.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 13.91 |
| Quick Ratio | 13.83 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -545.67 |
Financial Efficiency
Return on equity (ROE) is -78.81% and return on invested capital (ROIC) is -49.45%.
| Return on Equity (ROE) | -78.81% |
| Return on Assets (ROA) | -45.37% |
| Return on Capital (ROIC) | -49.45% |
| Revenue Per Employee | 1.10M |
| Profits Per Employee | -1.45M |
| Employee Count | 6 |
| Asset Turnover | 0.54 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 1.74, so Actinogen Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.74 |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | 34,730 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Actinogen Medical had revenue of 6.63 million and -8.70 million in losses. Loss per share was -0.00.
| Revenue | 6.63M |
| Gross Profit | 6.63M |
| Operating Income | -8.84M |
| Pretax Income | -8.70M |
| Net Income | -8.70M |
| EBITDA | -8.62M |
| EBIT | -8.84M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 6.31 million in cash and 212,883 in debt, giving a net cash position of 6.09 million.
| Cash & Cash Equivalents | 6.31M |
| Total Debt | 212,883 |
| Net Cash | 6.09M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 13.14M |
| Book Value Per Share | 0.00 |
| Working Capital | 11.69M |
Cash Flow
In the last 12 months, operating cash flow was -11.31 million and capital expenditures -5,446, giving a free cash flow of -11.32 million.
| Operating Cash Flow | -11.31M |
| Capital Expenditures | -5,446 |
| Free Cash Flow | -11.32M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -133.47% and -131.34%.
| Gross Margin | 100.00% |
| Operating Margin | -133.47% |
| Pretax Margin | -131.34% |
| Profit Margin | -131.34% |
| EBITDA Margin | -130.10% |
| EBIT Margin | -133.47% |
| FCF Margin | n/a |
Dividends & Yields
Actinogen Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.69% |
| Shareholder Yield | -20.69% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Actinogen Medical has an Altman Z-Score of 17.05.
| Altman Z-Score | 17.05 |
| Piotroski F-Score | n/a |